This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Brown & Brown (BRO) to Foray Into Ireland With O'Leary Insurances
by Zacks Equity Research
Brown & Brown's (BRO) acquisition of O'Leary Insurances is set to help the acquirer to penetrate into the Irish insurance market.
Arthur J. Gallagher (AJG) Announces Premier Brokerage Buyout
by Zacks Equity Research
Arthur J. Gallagher's (AJG) buyout of Premier Brokerage Services is likely to boost its life brokerage capabilities in the high-end agent and advisory space.
Brown & Brown (BRO) Subsidiary Buys Assets of South & Western
by Zacks Equity Research
Brown & Brown (BRO) subsidiary's acquisition of South & Western will enhance its insurance business.
6 Insurance Brokerage Stocks to Gain From Increased Demand
by Tanuka De
Increased demand for insurance products, given growing aging population, baby boomers and millennials, should drive insurance brokers like MMC, AON, EHTH, BRO, AJG and WLTW amid pandemic-led challenges.
Marsh & McLennan (MMC) Arm Purchases INSPRO in Nebraska
by Zacks Equity Research
Marsh & McLennan's (MMC) subsidiary MMA buys INSPRO in Nebraska to boost its portfolio and expand its capabilities.
Marsh & McLennan (MMC) Arm Buys Heritage Insurance in Kentucky
by Zacks Equity Research
Marsh & McLennan's (MMC) subsidiary MMA purchases Heritage Insurance to boost its portfolio and expand its capabilities.
Marsh & McLennan's (MMC) Unit Surpasses the $321.4B Mark
by Zacks Equity Research
Marsh & McLennan's (MMC) subsidiary passes the $321.4-billion mark in assets under management (AUM).
Here's Why You Should Add Aon (AON) Stock to Your Portfolio
by Zacks Equity Research
Aon's (AON) strategic measures and cost-curbing initiatives bode well, which in turn, make the stock a promising option.
Why Should You Hold Marsh & McLennan (MMC) in Your Portfolio?
by Zacks Equity Research
Riding high on its strategic moves and solid third-quarter results, Marsh & McLennan (MMC) holds potential to reap benefits for investors.
Aon's (AON) Q3 Earnings Surpass Estimates, Increase Y/Y
by Zacks Equity Research
Aon's (AON) third-quarter results reflect lower expenses and a solid contribution from its Commercial Risk Solutions and Reinsurance Solutions segments.
Arthur J. Gallagher (AJG) Q3 Earnings & Revenues Top, Up Y/Y
by Zacks Equity Research
Arthur J. Gallagher (AJG) Q3 earnings reflect lower expenses, higher adjusted revenues and strong margin expansion across Brokerage and Risk Management segments.
Marsh & McLennan's (MMC) Q3 Earnings Top Estimates, Rise Y/Y
by Zacks Equity Research
Marsh & McLennan's (MMC) Q3 results reflect lower costs as well as a robust performance by its Risk and Insurance Services segment.
Marsh & McLennan (MMC) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Marsh & McLennan (MMC) delivered earnings and revenue surprises of 10.81% and 3.39%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Insurance Stocks Earnings on Oct 29: MMC, WLTW and More
by Tanuka De
Insurers' third quarter results are likely to have benefited from improved pricing, strong retention, new business, partially offset by cat losses and lower interest rate.
Should You Buy Marsh & McLennan Companies (MMC) Ahead of Earnings?
by Zacks Equity Research
Marsh & McLennan Companies (MMC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
What Awaits Arthur J. Gallagher (AJG) This Earnings Season?
by Zacks Equity Research
Arthur J. Gallagher's (AJG) Q3 results are likely to reflect new business generation, solid retentions and higher property and casualty rates.
What's in the Offing for Aon (AON) This Earnings Season?
by Zacks Equity Research
Aon's (AON) third-quarter 2020 results are likely to reflect weak performance at most of the segments barring Reinsurance Solutions, partly offset by higher cash flows.
Marsh & McLennan (MMC) to Report Q3 Earnings: What to Expect
by Zacks Equity Research
Marsh & McLennan's (MMC) third-quarter 2020 results are likely to witness muted revenues.
What's in the Cards for Willis Towers (WLTW) in Q3 Earnings?
by Zacks Equity Research
Willis Towers (WLTW) Q3 earnings are likely to have benefited from higher commissions, net new business, and favorable renewals. However, revenues may have been under pressure due to the COVID-19 pandemic.
Marsh & McLennan (MMC) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Marsh & McLennan (MMC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
eHealth (EHTH) to Report Q3 Earnings: Is a Beat in Store?
by Zacks Equity Research
eHealth's (EHTH) Q3 results are likely to benefit from solid performance at Medicare and individual and family plan business.
Why Should You Retain Marsh & McLennan in Your Portfolio?
by Zacks Equity Research
Owing to strategic measures and an encouraging solvency position, Marsh & McLennan (MMC) holds enough promises for investors' portfolio.
Marsh & McLennan's (MMC) Arm Ties Up With Triterras Fintech
by Zacks Equity Research
Marsh & McLennan's (MMC) Marsh arm forges an alliance with Triterras Fintech to provide customers with a digitized access to credit insurance.
MMC vs. AJG: Which Insurance Brokerage Stock Should You Hold?
by Zacks Equity Research
Marsh & McLennan (MMC) and Arthur J. Gallagher (AJG) are poised to grow in the thriving insurance brokerage space. Through comparisons, we discover which stock is stronger, based on the fundamentals.
Marsh & McLennan (MMC): Strong Industry, Solid Earnings Estimate Revisions
by Zacks Equity Research
Marsh & McLennan (MMC) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.